Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Journal of Personalized Medicine
|
February 25, 2022
Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro
Alice Filipe, Periklis Katopodis, Dimple Chudasama, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
Hugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Journal of Clinical Medicine
|
April 13, 2023
Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting
Zena Alizzi, Patricia Roxburgh, Douglas Cartwright, et al.
International Journal of Molecular Medicine
|
March 2, 2021
COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Periklis Katopodis, Rachel Kerslake, Julie Davies, et al.
Archives of Gynecology and Obstetrics
|
April 5, 2016
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities
Christina Fotopoulou, Benjamin P Jones, Konstantinos Savvatis, et al.
International Journal of Molecular Medicine
|
November 3, 2018
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
Karly-Rai Rogers-Broadway, Juhi Kumar, Cristina Sisu, et al.
British Journal of Cancer
|
December 10, 2019
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
Corran Roberts, Victoria Y Strauss, Sylwia Kopijasz, et al.
British Journal of Cancer
|
January 20, 2024
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
Shibani Nicum, Naomi McGregor, Rachel Austin, et al.
Cancers
|
March 15, 2019
Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
Dimple Chudasama, Periklis Katopodis, Nick Stone, et al.
Gynecologic Oncology
|
January 15, 2020
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial
Robert D Morgan, Susana Banerjee, Marcia Hall, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Journal of Personalized Medicine
|
February 25, 2022
Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro
Alice Filipe, Periklis Katopodis, Dimple Chudasama, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
Hugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
Journal of Clinical Medicine
|
April 13, 2023
Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting
Zena Alizzi, Patricia Roxburgh, Douglas Cartwright, et al.
International Journal of Molecular Medicine
|
March 2, 2021
COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Periklis Katopodis, Rachel Kerslake, Julie Davies, et al.
Archives of Gynecology and Obstetrics
|
April 5, 2016
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities
Christina Fotopoulou, Benjamin P Jones, Konstantinos Savvatis, et al.
International Journal of Molecular Medicine
|
November 3, 2018
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
Karly-Rai Rogers-Broadway, Juhi Kumar, Cristina Sisu, et al.
British Journal of Cancer
|
December 10, 2019
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
Corran Roberts, Victoria Y Strauss, Sylwia Kopijasz, et al.
British Journal of Cancer
|
January 20, 2024
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
Shibani Nicum, Naomi McGregor, Rachel Austin, et al.
Cancers
|
March 15, 2019
Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
Dimple Chudasama, Periklis Katopodis, Nick Stone, et al.
Gynecologic Oncology
|
January 15, 2020
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial
Robert D Morgan, Susana Banerjee, Marcia Hall, et al.
Page
of 8